INmune Bio Ownership 2024 | Who Owns INmune Bio Now?
Institutional Ownership
4.37%
Insider Ownership
32.23%
Retail Ownership
63.39%
Institutional Holders
18.00
INmune Bio Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BLACKROCK INC. | 4.51% | 0.00% | 812,895 | 572,729 | 238.47% | 7,169,735 | Jun 30, 2024 |
| VANGUARD GROUP INC | 3.49% | 0.00% | 628,299 | 86,970 | 16.07% | 5,541,597 | Jun 30, 2024 |
| CVI HOLDINGS, LLC | 3.31% | 4.54% | 596,372 | 596,372 | 100.00% | 5,260,001 | Jun 30, 2024 |
| PRAETORIAN PR LLC | 2.69% | 1.57% | 485,000 | 485,000 | 100.00% | 4,277,700 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.79% | 0.00% | 323,204 | 152,402 | 89.23% | 2,850,938 | Jun 30, 2024 |
| RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC. | 1.26% | 0.00% | 227,534 | 227,534 | 100.00% | 2,006,850 | Jun 30, 2024 |
| RHENMAN & PARTNERS ASSET MANAGEMENT AB | 0.99% | 0.15% | 178,284 | - | - | 1,572,465 | Jun 30, 2024 |
| STATE STREET CORP | 0.93% | 0.00% | 167,590 | 122,527 | 271.90% | 1,478,144,000 | Jun 30, 2024 |
| MAI CAPITAL MANAGEMENT | 0.89% | 0.01% | 160,582 | -20,828 | -11.48% | 1,416,333 | Jun 30, 2024 |
| MARSHALL WACE, LLP | 0.64% | 0.00% | 115,916 | 89,091 | 332.12% | 1,022,380 | Jun 30, 2024 |
| DEUTSCHE BANK AG\ | 0.61% | 0.00% | 109,848 | - | - | 968,859 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.51% | 0.00% | 92,670 | -66,522 | -41.79% | 817,349 | Jun 30, 2024 |
| ROYAL BANK OF CANADA | 0.35% | 0.00% | 62,601 | -20,135 | -24.34% | 552,000 | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | 0.33% | 0.00% | 58,600 | 32,511 | 124.62% | 516,852 | Jun 30, 2024 |
| WESTSIDE INVESTMENT MANAGEMENT, INC. | 0.25% | 0.09% | 45,340 | 10,950 | 31.84% | 399,903 | Jun 30, 2024 |
| UBS GROUP AG | 0.22% | 0.00% | 40,293 | 1,993 | 5.20% | 355,384 | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.21% | 0.00% | 37,275 | 37,275 | 100.00% | 328,766 | Jun 30, 2024 |
| FERMATA ADVISORS, LLC | 0.19% | 0.07% | 34,140 | 2,689 | 8.55% | 301,115 | Jun 30, 2024 |
| LAIRD NORTON TRUST COMPANY, LLC | 0.17% | 0.04% | 31,500 | - | - | 277,830 | Jun 30, 2024 |
| MORGAN STANLEY | 0.16% | - | 28,375 | 896 | 3.26% | 250,268 | Jun 30, 2024 |
INmune Bio's largest institutional shareholder is BLACKROCK INC., holding 4.51% of the company's total share outstanding, currently valued at $7.17M. The top 10 institutional shareholders own together 20.50% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| CVI HOLDINGS, LLC | 3.31% | 4.54% | 596,372 | 596,372 | 100.00% | 5,260,001 | Jun 30, 2024 |
| PRAETORIAN PR LLC | 2.69% | 1.57% | 485,000 | 485,000 | 100.00% | 4,277,700 | Jun 30, 2024 |
| RHENMAN & PARTNERS ASSET MANAGEMENT AB | 0.99% | 0.15% | 178,284 | - | - | 1,572,465 | Jun 30, 2024 |
| CORTON CAPITAL INC. | 0.11% | 0.10% | 20,545 | 20,545 | 100.00% | 181,207 | Jun 30, 2024 |
| WESTSIDE INVESTMENT MANAGEMENT, INC. | 0.25% | 0.09% | 45,340 | 10,950 | 31.84% | 399,903 | Jun 30, 2024 |
| FERMATA ADVISORS, LLC | 0.19% | 0.07% | 34,140 | 2,689 | 8.55% | 301,115 | Jun 30, 2024 |
| LAIRD NORTON TRUST COMPANY, LLC | 0.17% | 0.04% | 31,500 | - | - | 277,830 | Jun 30, 2024 |
| ALPINE GLOBAL MANAGEMENT, LLC | 0.06% | 0.02% | 11,559 | 11,559 | 100.00% | 101,950 | Jun 30, 2024 |
| REDWOOD WEALTH MANAGEMENT GROUP, LLC | 0.01% | 0.01% | 2,200 | 2,200 | 100.00% | 19,404 | Jun 30, 2024 |
| MAI CAPITAL MANAGEMENT | 0.89% | 0.01% | 160,582 | -20,828 | -11.48% | 1,416,333 | Jun 30, 2024 |
| FINANCIAL ADVOCATES INVESTMENT MANAGEMENT | 0.06% | 0.01% | 11,500 | 1,000 | 9.52% | 101,430 | Jun 30, 2024 |
| RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC. | 1.26% | 0.00% | 227,534 | 227,534 | 100.00% | 2,006,850 | Jun 30, 2024 |
| MARSHALL WACE, LLP | 0.64% | 0.00% | 115,916 | 89,091 | 332.12% | 1,022,380 | Jun 30, 2024 |
| CONTINUUM ADVISORY, LLC | 0.01% | 0.00% | 1,000 | - | - | 8,820 | Jun 30, 2024 |
| VALLEY NATIONAL ADVISERS INC | 0.01% | 0.00% | 1,000 | - | - | 8,000 | Jun 30, 2024 |
| NEWEDGE ADVISORS, LLC | 0.06% | 0.00% | 10,475 | - | - | 92,390 | Jun 30, 2024 |
| JANNEY MONTGOMERY SCOTT LLC | 0.12% | 0.00% | 21,688 | -119,223 | -84.61% | 191,000 | Jun 30, 2024 |
| MAN GROUP PLC | 0.14% | 0.00% | 24,388 | -16,161 | -39.86% | 215,102 | Jun 30, 2024 |
| DEUTSCHE BANK AG\ | 0.61% | 0.00% | 109,848 | - | - | 968,859 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.51% | 0.00% | 92,670 | -66,522 | -41.79% | 817,349 | Jun 30, 2024 |
The largest INmune Bio shareholder by % of total assets is CVI HOLDINGS, LLC. The company owns 596.37K shares of INmune Bio (INMB), representing 4.54% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| CVI HOLDINGS, LLC | 3.31% | 4.54% | 596,372 | 596,372 | 100.00% | 5,260,001 | Jun 30, 2024 |
| BLACKROCK INC. | 4.51% | 0.00% | 812,895 | 572,729 | 238.47% | 7,169,735 | Jun 30, 2024 |
| PRAETORIAN PR LLC | 2.69% | 1.57% | 485,000 | 485,000 | 100.00% | 4,277,700 | Jun 30, 2024 |
| RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC. | 1.26% | 0.00% | 227,534 | 227,534 | 100.00% | 2,006,850 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.79% | 0.00% | 323,204 | 152,402 | 89.23% | 2,850,938 | Jun 30, 2024 |
| STATE STREET CORP | 0.93% | 0.00% | 167,590 | 122,527 | 271.90% | 1,478,144,000 | Jun 30, 2024 |
| MARSHALL WACE, LLP | 0.64% | 0.00% | 115,916 | 89,091 | 332.12% | 1,022,380 | Jun 30, 2024 |
| VANGUARD GROUP INC | 3.49% | 0.00% | 628,299 | 86,970 | 16.07% | 5,541,597 | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.21% | 0.00% | 37,275 | 37,275 | 100.00% | 328,766 | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | 0.33% | 0.00% | 58,600 | 32,511 | 124.62% | 516,852 | Jun 30, 2024 |
| CORTON CAPITAL INC. | 0.11% | 0.10% | 20,545 | 20,545 | 100.00% | 181,207 | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 0.09% | - | 16,518 | 16,518 | 100.00% | 145,689 | Jun 30, 2024 |
| RHUMBLINE ADVISERS | 0.08% | 0.00% | 13,773 | 13,773 | 100.00% | 121,472 | Jun 30, 2024 |
| NEW YORK STATE COMMON RETIREMENT FUND | 0.06% | 0.00% | 11,600 | 11,600 | 100.00% | 102,000 | Jun 30, 2024 |
| ALPINE GLOBAL MANAGEMENT, LLC | 0.06% | 0.02% | 11,559 | 11,559 | 100.00% | 101,950 | Jun 30, 2024 |
| WESTSIDE INVESTMENT MANAGEMENT, INC. | 0.25% | 0.09% | 45,340 | 10,950 | 31.84% | 399,903 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.16% | - | 28,059 | 7,642 | 37.43% | 247,480,000 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.04% | 0.00% | 6,567 | 6,567 | 100.00% | 57,987 | Jun 30, 2024 |
| SIMPLEX TRADING, LLC | 0.03% | - | 5,786 | 5,786 | 100.00% | 51,000 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 0.03% | - | 5,202 | 5,202 | 100.00% | 45,882 | Jun 30, 2024 |
As of Jun 30 2024, INmune Bio's largest institutional buyer is CVI HOLDINGS, LLC. The company purchased 596.37K stocks of INMB, valued at $5.26M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| JANNEY MONTGOMERY SCOTT LLC | 0.12% | 0.00% | 21,688 | -119,223 | -84.61% | 191,000 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.06% | - | 11,657 | -75,948 | -86.69% | 102,815 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.51% | 0.00% | 92,670 | -66,522 | -41.79% | 817,349 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.02% | - | 3,384 | -40,781 | -92.34% | 29,847 | Jun 30, 2024 |
| HRT FINANCIAL LP | - | - | - | -29,898 | -100.00% | - | Jun 30, 2024 |
| MAI CAPITAL MANAGEMENT | 0.89% | 0.01% | 160,582 | -20,828 | -11.48% | 1,416,333 | Jun 30, 2024 |
| ROYAL BANK OF CANADA | 0.35% | 0.00% | 62,601 | -20,135 | -24.34% | 552,000 | Jun 30, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | - | - | - | -20,047 | -100.00% | - | Jun 30, 2024 |
| BREVAN HOWARD CAPITAL MANAGEMENT LP | - | - | - | -16,422 | -100.00% | - | Jun 30, 2024 |
| MAN GROUP PLC | 0.14% | 0.00% | 24,388 | -16,161 | -39.86% | 215,102 | Jun 30, 2024 |
| MARATHON TRADING INVESTMENT MANAGEMENT LLC | - | - | - | -14,500 | -100.00% | - | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | - | - | - | -13,441 | -100.00% | - | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | - | - | - | -13,438 | -100.00% | - | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | - | - | - | -11,059 | -100.00% | - | Jun 30, 2024 |
| LAURION CAPITAL MANAGEMENT LP | - | - | - | -11,011 | -100.00% | - | Jun 30, 2024 |
| BEACON POINTE ADVISORS, LLC | - | - | - | -10,368 | -100.00% | - | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -4,782 | -100.00% | - | Jun 30, 2024 |
| ADVISOR GROUP HOLDINGS, INC. | 0.05% | 0.00% | 8,163 | -4,107 | -33.47% | 71,997 | Jun 30, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -2,255 | -100.00% | - | Jun 30, 2024 |
| FMR LLC | 0.00% | - | 85 | -500 | -85.47% | 750 | Jun 30, 2024 |
As of Jun 30 2024, INmune Bio's biggest institutional seller is JANNEY MONTGOMERY SCOTT LLC. The company sold -0.12M shares of INMB, valued at $191.00K.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| CVI HOLDINGS, LLC | 3.31% | 4.54% | 596,372 | 596,372 | 100.00% | 5,260,001 | Jun 30, 2024 |
| PRAETORIAN PR LLC | 2.69% | 1.57% | 485,000 | 485,000 | 100.00% | 4,277,700 | Jun 30, 2024 |
| RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC. | 1.26% | 0.00% | 227,534 | 227,534 | 100.00% | 2,006,850 | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.21% | 0.00% | 37,275 | 37,275 | 100.00% | 328,766 | Jun 30, 2024 |
| CORTON CAPITAL INC. | 0.11% | 0.10% | 20,545 | 20,545 | 100.00% | 181,207 | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 0.09% | - | 16,518 | 16,518 | 100.00% | 145,689 | Jun 30, 2024 |
| RHUMBLINE ADVISERS | 0.08% | 0.00% | 13,773 | 13,773 | 100.00% | 121,472 | Jun 30, 2024 |
| NEW YORK STATE COMMON RETIREMENT FUND | 0.06% | 0.00% | 11,600 | 11,600 | 100.00% | 102,000 | Jun 30, 2024 |
| ALPINE GLOBAL MANAGEMENT, LLC | 0.06% | 0.02% | 11,559 | 11,559 | 100.00% | 101,950 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.04% | 0.00% | 6,567 | 6,567 | 100.00% | 57,987 | Jun 30, 2024 |
| BARCLAYS PLC | 0.02% | - | 4,138 | 4,138 | 100.00% | 37,000 | Jun 30, 2024 |
| REDWOOD WEALTH MANAGEMENT GROUP, LLC | 0.01% | 0.01% | 2,200 | 2,200 | 100.00% | 19,404 | Jun 30, 2024 |
| LEGAL & GENERAL GROUP PLC | 0.01% | - | 1,358 | 1,358 | 100.00% | 11,978 | Jun 30, 2024 |
| AMERITAS INVESTMENT PARTNERS, INC. | 0.01% | 0.00% | 1,196 | 1,196 | 100.00% | 10,549 | Jun 30, 2024 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 0.00% | - | 885 | 885 | 100.00% | 7,806 | Jun 30, 2024 |
| BNP PARIBAS ARBITRAGE, SNC | 0.00% | - | 879 | 879 | 100.00% | 7,753 | Jun 30, 2024 |
| AMALGAMATED BANK | 0.00% | - | 422 | 422 | 100.00% | 4,000 | Jun 30, 2024 |
INmune Bio's largest new institutional shareholder by number of shares is CVI HOLDINGS, LLC, purchased 596.37K shares, valued at $5.26M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| HRT FINANCIAL LP | - | - | - | -29,898 | -100.00% | - | Jun 30, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | - | - | - | -20,047 | -100.00% | - | Jun 30, 2024 |
| BREVAN HOWARD CAPITAL MANAGEMENT LP | - | - | - | -16,422 | -100.00% | - | Jun 30, 2024 |
| MARATHON TRADING INVESTMENT MANAGEMENT LLC | - | - | - | -14,500 | -100.00% | - | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | - | - | - | -13,441 | -100.00% | - | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | - | - | - | -13,438 | -100.00% | - | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | - | - | - | -11,059 | -100.00% | - | Jun 30, 2024 |
| LAURION CAPITAL MANAGEMENT LP | - | - | - | -11,011 | -100.00% | - | Jun 30, 2024 |
| BEACON POINTE ADVISORS, LLC | - | - | - | -10,368 | -100.00% | - | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -4,782 | -100.00% | - | Jun 30, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -2,255 | -100.00% | - | Jun 30, 2024 |
| MACQUARIE GROUP LTD | - | - | - | -444 | -100.00% | - | Jun 30, 2024 |
| FNY INVESTMENT ADVISERS, LLC | - | - | - | -100 | -100.00% | - | Jun 30, 2024 |
INmune Bio's largest sold out institutional shareholder by shares sold is HRT FINANCIAL LP, sold -29.90K shares, valued at -, as of undefined.
INmune Bio Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| FIDELITY COMMONWEALTH TRUST | 0.01% | 37,821 | 620 | 1.67% | Feb 29, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.01% | 5,000 | - | - | Mar 31, 2024 |
| ALPS ETF Trust | 0.00% | 17,301 | - | - | Feb 29, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 527,892 | -165,308 | -23.85% | Mar 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 122,945 | 900 | 0.74% | Feb 29, 2024 |
| ADVISORS' INNER CIRCLE FUND | 0.00% | 5,344 | - | - | Jan 31, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 2,010 | - | - | Mar 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 3,898 | -566 | -12.68% | Mar 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 5,159 | - | - | Jan 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 651 | - | - | Mar 31, 2024 |
| FLEXSHARES TRUST | 0.00% | 2,316 | - | - | Jan 31, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 2,867 | 1,535 | 115.24% | Feb 29, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 1,744 | 1,744 | - | Jan 31, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 1,570 | 503 | 47.14% | Jan 31, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 5,679 | - | - | Jan 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 1,983 | - | - | Mar 31, 2024 |
| iSHARES TRUST | 0.00% | 25,974 | -1 | -0.00% | Mar 31, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 459 | - | - | Mar 31, 2024 |
INmune Bio's largest mutual fund holder by % of total assets is "FIDELITY COMMONWEALTH TRUST", owning 37.82K shares, compromising 0.01% of its total assets.
INmune Bio Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 18 | -66.67% |
| 31 Mar, 24 | 54 | 5.88% |
| 31 Dec, 23 | 51 | 27.50% |
| 30 Sep, 23 | 40 | 11.11% |
| 30 Jun, 23 | 36 | 5.88% |
| 31 Mar, 23 | 34 | -2.86% |
| 31 Dec, 22 | 35 | 2.94% |
| 30 Sep, 22 | 34 | -5.56% |
| 30 Jun, 22 | 36 | 5.88% |
| 31 Mar, 22 | 34 | -19.05% |
| 31 Dec, 21 | 42 | -8.70% |
| 30 Sep, 21 | 46 | 12.20% |
| 30 Jun, 21 | 41 | 32.26% |
| 31 Mar, 21 | 31 | 29.17% |
| 31 Dec, 20 | 24 | -4.00% |
| 30 Sep, 20 | 25 | 108.33% |
| 30 Jun, 20 | 12 | 20.00% |
| 31 Mar, 20 | 10 | -9.09% |
| 31 Dec, 19 | 11 | 10.00% |
| 30 Sep, 19 | 10 | 42.86% |
| 30 Jun, 19 | 7 | 40.00% |
| 31 Mar, 19 | 5 | - |
As of 30 Jun 24, 18 institutions are holding INmune Bio's shares, representing a decrease of -66.67% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 788,224 | -71.22% |
| 31 Mar, 24 | 2,739,265 | 19.53% |
| 31 Dec, 23 | 2,291,722 | 7.43% |
| 30 Sep, 23 | 2,133,239 | -2.40% |
| 30 Jun, 23 | 2,185,670 | 21.16% |
| 31 Mar, 23 | 1,803,987 | 9.66% |
| 31 Dec, 22 | 1,645,007 | -13.99% |
| 30 Sep, 22 | 1,912,571 | -4.89% |
| 30 Jun, 22 | 2,010,810 | -12.35% |
| 31 Mar, 22 | 2,294,095 | -7.19% |
| 31 Dec, 21 | 2,471,812 | 28.41% |
| 30 Sep, 21 | 1,925,002 | 10.74% |
| 30 Jun, 21 | 1,738,369 | 34.57% |
| 31 Mar, 21 | 1,291,756 | 53.86% |
| 31 Dec, 20 | 839,584 | -13.05% |
| 30 Sep, 20 | 965,641 | 169.22% |
| 30 Jun, 20 | 358,675 | 4.70% |
| 31 Mar, 20 | 342,563 | 20.95% |
| 31 Dec, 19 | 283,216 | 3.10% |
| 30 Sep, 19 | 274,688 | 608.51% |
| 30 Jun, 19 | 38,770 | -14.07% |
| 31 Mar, 19 | 45,117 | - |
INmune Bio (INMB) has 788.22K shares outstanding as of 30 Jun 24, down -71.22% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 4.37% | 1.88% |
| 31 Mar, 24 | 15.26% | 9.42% |
| 31 Dec, 23 | 12.73% | 9.01% |
| 30 Sep, 23 | 11.89% | 8.01% |
| 30 Jun, 23 | 12.18% | 12.05% |
| 31 Mar, 23 | 10.05% | 11.94% |
| 31 Dec, 22 | 9.18% | 8.08% |
| 30 Sep, 22 | 10.66% | 8.49% |
| 30 Jun, 22 | 11.20% | 6.80% |
| 31 Mar, 22 | 12.84% | 5.47% |
| 31 Dec, 21 | 15.32% | 12.42% |
| 30 Sep, 21 | 11.11% | 8.24% |
| 30 Jun, 21 | 11.61% | 14.27% |
| 31 Mar, 21 | 9.02% | 21.38% |
| 31 Dec, 20 | 6.50% | 11.64% |
| 30 Sep, 20 | 7.47% | 67.74% |
| 30 Jun, 20 | 3.32% | 32.69% |
| 31 Mar, 20 | 3.19% | 45.90% |
| 31 Dec, 19 | 2.64% | 40.45% |
| 30 Sep, 19 | 2.55% | 1749.78% |
| 30 Jun, 19 | 0.38% | 165.41% |
| 31 Mar, 19 | 0.48% | - |
As of 30 Jun 24, INmune Bio is held by 4.37% institutional shareholders, representing a 1.88% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 12 | -57.14% |
| 31 Mar, 24 | 28 | - |
| 31 Dec, 23 | 28 | 100.00% |
| 30 Sep, 23 | 14 | -6.67% |
| 30 Jun, 23 | 15 | -11.76% |
| 31 Mar, 23 | 17 | - |
| 31 Dec, 22 | 17 | 41.67% |
| 30 Sep, 22 | 12 | -14.29% |
| 30 Jun, 22 | 14 | 27.27% |
| 31 Mar, 22 | 11 | -54.17% |
| 31 Dec, 21 | 24 | -4.00% |
| 30 Sep, 21 | 25 | 4.17% |
| 30 Jun, 21 | 24 | - |
| 31 Mar, 21 | 24 | 50.00% |
| 31 Dec, 20 | 16 | -15.79% |
| 30 Sep, 20 | 19 | 171.43% |
| 30 Jun, 20 | 7 | 16.67% |
| 31 Mar, 20 | 6 | - |
| 31 Dec, 19 | 6 | -25.00% |
| 30 Sep, 19 | 8 | 60.00% |
| 30 Jun, 19 | 5 | - |
| 31 Mar, 19 | 5 | - |
12 institutional shareholders have increased their position in INMB stock as of 30 Jun 24 compared to 28 in the previous quarter (a -57.14% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 1 | -91.67% |
| 31 Mar, 24 | 12 | 50.00% |
| 31 Dec, 23 | 8 | -11.11% |
| 30 Sep, 23 | 9 | - |
| 30 Jun, 23 | 9 | 28.57% |
| 31 Mar, 23 | 7 | - |
| 31 Dec, 22 | 7 | -12.50% |
| 30 Sep, 22 | 8 | -27.27% |
| 30 Jun, 22 | 11 | 22.22% |
| 31 Mar, 22 | 9 | -18.18% |
| 31 Dec, 21 | 11 | 37.50% |
| 30 Sep, 21 | 8 | 60.00% |
| 30 Jun, 21 | 5 | 150.00% |
| 31 Mar, 21 | 2 | -33.33% |
| 31 Dec, 20 | 3 | - |
| 30 Sep, 20 | 3 | - |
| 30 Jun, 20 | 3 | 50.00% |
| 31 Mar, 20 | 2 | 100.00% |
| 31 Dec, 19 | 1 | - |
| 30 Sep, 19 | - | -100.00% |
| 30 Jun, 19 | 1 | - |
| 31 Mar, 19 | - | - |
1 institutional shareholders have reduced their position in INMB stock as of 30 Jun 24 compared to 12 in the previous quarter (a -91.67% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 18 | -66.67% | 788,224 | -71.22% | 4.37% | 1.88% | 12 | -57.14% | 1 | -91.67% |
| 31 Mar, 24 | 54 | 5.88% | 2,739,265 | 19.53% | 15.26% | 9.42% | 28 | - | 12 | 50.00% |
| 31 Dec, 23 | 51 | 27.50% | 2,291,722 | 7.43% | 12.73% | 9.01% | 28 | 100.00% | 8 | -11.11% |
| 30 Sep, 23 | 40 | 11.11% | 2,133,239 | -2.40% | 11.89% | 8.01% | 14 | -6.67% | 9 | - |
| 30 Jun, 23 | 36 | 5.88% | 2,185,670 | 21.16% | 12.18% | 12.05% | 15 | -11.76% | 9 | 28.57% |
| 31 Mar, 23 | 34 | -2.86% | 1,803,987 | 9.66% | 10.05% | 11.94% | 17 | - | 7 | - |
| 31 Dec, 22 | 35 | 2.94% | 1,645,007 | -13.99% | 9.18% | 8.08% | 17 | 41.67% | 7 | -12.50% |
| 30 Sep, 22 | 34 | -5.56% | 1,912,571 | -4.89% | 10.66% | 8.49% | 12 | -14.29% | 8 | -27.27% |
| 30 Jun, 22 | 36 | 5.88% | 2,010,810 | -12.35% | 11.20% | 6.80% | 14 | 27.27% | 11 | 22.22% |
| 31 Mar, 22 | 34 | -19.05% | 2,294,095 | -7.19% | 12.84% | 5.47% | 11 | -54.17% | 9 | -18.18% |
| 31 Dec, 21 | 42 | -8.70% | 2,471,812 | 28.41% | 15.32% | 12.42% | 24 | -4.00% | 11 | 37.50% |
| 30 Sep, 21 | 46 | 12.20% | 1,925,002 | 10.74% | 11.11% | 8.24% | 25 | 4.17% | 8 | 60.00% |
| 30 Jun, 21 | 41 | 32.26% | 1,738,369 | 34.57% | 11.61% | 14.27% | 24 | - | 5 | 150.00% |
| 31 Mar, 21 | 31 | 29.17% | 1,291,756 | 53.86% | 9.02% | 21.38% | 24 | 50.00% | 2 | -33.33% |
| 31 Dec, 20 | 24 | -4.00% | 839,584 | -13.05% | 6.50% | 11.64% | 16 | -15.79% | 3 | - |
| 30 Sep, 20 | 25 | 108.33% | 965,641 | 169.22% | 7.47% | 67.74% | 19 | 171.43% | 3 | - |
| 30 Jun, 20 | 12 | 20.00% | 358,675 | 4.70% | 3.32% | 32.69% | 7 | 16.67% | 3 | 50.00% |
| 31 Mar, 20 | 10 | -9.09% | 342,563 | 20.95% | 3.19% | 45.90% | 6 | - | 2 | 100.00% |
| 31 Dec, 19 | 11 | 10.00% | 283,216 | 3.10% | 2.64% | 40.45% | 6 | -25.00% | 1 | - |
| 30 Sep, 19 | 10 | 42.86% | 274,688 | 608.51% | 2.55% | 1749.78% | 8 | 60.00% | - | -100.00% |
| 30 Jun, 19 | 7 | 40.00% | 38,770 | -14.07% | 0.38% | 165.41% | 5 | - | 1 | - |
| 31 Mar, 19 | 5 | - | 45,117 | - | 0.48% | - | 5 | - | - | - |
INmune Bio Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Insider Sells
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
All Insider Owners Trades
The last insider buy of INMB was made by Juda Scott on Jun 26 2024, buying 5,000 shares at $7.27 per share (worth $36.35K).
INmune Bio Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | 26 | - | - |
| Q4 2023 | 1 | - | - |
| Q3 2023 | - | 1 | - |
| Q1 2023 | 8 | - | - |
| Q2 2022 | 2 | - | - |
| Q1 2022 | 14 | - | - |
| Q4 2021 | 1 | 10 | 10.00% |
| Q3 2021 | 3 | 11 | 27.27% |
| Q2 2021 | 14 | 2 | 700.00% |
| Q1 2021 | 11 | 1 | 1100.00% |
| Q1 2020 | - | 1 | - |
| Q4 2019 | 11 | 1 | 1100.00% |
| Q3 2019 | 23 | - | - |
| Q2 2019 | 10 | 1 | 1000.00% |
| Q1 2019 | - | 12 | - |
26 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by INmune Bio's insiders, as of Q2 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | 9 | - | - |
| Q4 2023 | 1 | - | - |
| Q3 2023 | - | 1 | - |
| Q1 2023 | 1 | - | - |
| Q2 2022 | 2 | - | - |
| Q1 2022 | - | - | - |
| Q4 2021 | 1 | 10 | 10.00% |
| Q3 2021 | - | 8 | - |
| Q2 2021 | - | 2 | - |
| Q1 2021 | - | 1 | - |
| Q1 2020 | - | 1 | - |
| Q4 2019 | - | - | - |
| Q3 2019 | 23 | - | - |
| Q2 2019 | 10 | - | - |
| Q1 2019 | - | - | - |
As of Q2 2024, Insider owners conducted 9 open market buy trades and 0 open market sell trades of INmune Bio's stocks.
INmune Bio Peer Ownership
| Ticker | Company |
|---|---|
| CUE | Cue Biopharma, Inc. |
| AVXL | Anavex Life Sciences Corp. |
| DBTX | Decibel Therapeutics, Inc. |
| TCRX | TScan Therapeutics, Inc. |
| AVTE | Aerovate Therapeutics, Inc. |
| DRMA | Dermata Therapeutics, Inc. |
| ANTX | AN2 Therapeutics, Inc. |
| BIVI | BioVie Inc. |
| INAB | IN8bio, Inc. |
| TFFP | TFF Pharmaceuticals, Inc. |
| ANEB | Anebulo Pharmaceuticals, Inc. |
| SAVA | Cassava Sciences, Inc. |
| CGTX | Cognition Therapeutics, Inc. |
| ANIX | Anixa Biosciences, Inc. |
| PYPD | PolyPid Ltd. |
| ELYM | Eliem Therapeutics, Inc. |
INMB Ownership FAQ
Who Owns INmune Bio?
INmune Bio is owned by institutional shareholders (4.37%), insiders (32.23%), and public (63.39%). The largest institutional shareholder of INmune Bio is BLACKROCK INC. (4.51% of total shares) and the top mutual fund owner is FIDELITY COMMONWEALTH TRUST (0.01% of total shares).
Who are the major institutional shareholders of INmune Bio?
INmune Bio's major institutional shareholders are BLACKROCK INC., VANGUARD GROUP INC, CVI HOLDINGS, LLC, PRAETORIAN PR LLC, and GEODE CAPITAL MANAGEMENT, LLC. The top five shareholders own together 15.79% of the company's share outstanding.
How many INmune Bio shareholders are there?
As of Jun 2024, there are 18 institutional shareholders of INmune Bio.
What percentage of INmune Bio is owned by BLACKROCK INC?
BLACKROCK INC owns 812.9K shares of INmune Bio, representing 4.51% of the company's total shares outstanding, valued at $7.17M (as of Jun 2024).
What percentage of INmune Bio is owned by VANGUARD GROUP INC?
As of Jun 2024, VANGUARD GROUP INC holds 628.3K shares of INmune Bio (INMB), compromising 3.49% of the company, valued at $5.54M.
What percentage of INmune Bio is owned by CVI HOLDINGS, LLC?
CVI HOLDINGS, LLC is the third largest holder of INmune Bio. The company owns 596.37K of the company's shares outstanding (worth $5.26M).